The data are limited at this time, but case reports show that people taking GLP-1 meds reported increased energy, reduced pain, and reduced fatigue
Maintenance: Return to 600 mcg daily for Weeks 58+
GLP-1 agonists can help lower inflammation, a common lipedema issue, by improving metabolic health and reducing adipose tissue
Starting in the new year, Independence Blue Cross, the regions largest health insurer, will no longer cover anti-obesity drugs like Ozempic and Wegovy when theyre prescribed solely for weight loss
Future perspectives and outstanding questions Despite substantial progress, several unmet needs and key questions require investigation to fully realize the therapeutic potential of GLP-1-based therapies in MASLD/MASH
Poor sleep disrupting hormonal regulation Sleep deprivation is a weight gain accelerator